Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrolaminar vs Ilioinguinal Block for Pediatric Inguinal Hernia
NCT04266132Unknown
- Start
- May 2020
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Randomised, single-blind trial (2 arms). Primary endpoint: Time to first analgesic request at 24 hours. Status: unknown.
Beyond the preview
Go deeper on NCT04266132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04266132.